Transderm Scop belongs to the anticholinergic category of medications. Anticholinergics reduce the secretion of fluids, slow down stomach and intestinal function and dilate the pupils. Transderm Scop is used to relieve the symptoms of motion sickness including nausea, vomiting, and dizziness. Transderm Scop is dispensed in the form of patches to be placed behind the ear. Patches must be applied at least four hours before experiencing the symptoms of motion sickness. Apply one patch to a clean, dry, hairless area behind the ear. The effect of each patch lasts up to 3 days. Dispose of the patch after the third day or if it is no longer needed. Wrap the patch in tissue or paper to avoid unnecessary exposure. Wash your hands and the area behind your ear thoroughly to remove any traces of Transderm Scop. If you need a new patch, place a fresh one behind your other ear.
Warnings Precautions
If you have kidney or liver disease, an enlarged prostate, difficulty urinating, bladder problems, or glaucoma, inform your doctor before using Transderm Scop. Transderm Scop is in the C FDA pregnancy category, meaning that it has a harmful effect on the fetus. It is not clear whether Transderm Scop is passed onto breast milk. Do not use Transderm Scop if you are pregnant or breast-feeding without consulting your doctor first. Since children have a higher sensitivity to scopolamine, Transderm Scop is not recommended for use by children.
Missing a Dose
In case of missing a patch, remove the old patch as soon as you remember. Apply a new patch to an area behind the other ear. Skip the missed dose if it is almost time for another patch. Never apply two patches of Transderm Scop at the sane time.
Possible Side Effects
If you experience an allergic reaction (difficulty in breathing; throat congestion; swelling of the lips, tongue, or face; or hives), discontinue the treatment with Transderm Scop and seek medical help immediately. If you experience drowsiness; dry mouth, nose, or throat; restlessness, agitation, excitement, or insomnia; blurred vision; dizziness; decreased appetite, nausea, or vomiting; difficulty urinating; or an irregular or rapid heartbeat, continue the treatment and ask your doctor for advice. When treatment lasting over 3 days is discontinued, cases of nausea, vomiting, dizziness, headache, and poor coordination have been reported and you should be aware of these side effects when terminating the treatment with Transderm Scop. Other, less serious side effects may also occur. If you detect any symptoms that appear unusual or are particularly irritating, consult your doctor.
Storage
Store at controlled room temperature of between 20?°C – 25?°C (68?°F – 77?°F).
Overdose
Drowsiness, dizziness, agitation, excitability, seizures or convulsions, hallucinations are among the symptoms of a Transderm Scop overdose. Seek medical help at once as a Transderm Scop ovedose may be lethal.
More Information
Transderm Scop may cause dizziness, drowsiness, or blurred vision. Exercise caution when driving or operating heavy machinery. Avoid hazardous activities. Alcohol may increase drowsiness and dizziness during treatment with Transderm Scop. Alcohol consumption should be limited.
Transderm Scop resources:
http://www.rxlist.com/cgi/generic2/transscop.htm
http://www.medicinenet.com/scopolamine/article.htm
http://www.drugdigest.org/DD/DVH/Uses/0,3915,602%7CScopolamine+Patch,00.html
Related posts: